MA29039B1 - Dibenzylamines et derives - Google Patents
Dibenzylamines et derivesInfo
- Publication number
- MA29039B1 MA29039B1 MA29936A MA29936A MA29039B1 MA 29039 B1 MA29039 B1 MA 29039B1 MA 29936 A MA29936 A MA 29936A MA 29936 A MA29936 A MA 29936A MA 29039 B1 MA29039 B1 MA 29039B1
- Authority
- MA
- Morocco
- Prior art keywords
- dibenzylamines
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63043404P | 2004-11-23 | 2004-11-23 | |
| US71561705P | 2005-09-12 | 2005-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA29039B1 true MA29039B1 (fr) | 2007-11-01 |
Family
ID=35828305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA29936A MA29039B1 (fr) | 2004-11-23 | 2007-05-23 | Dibenzylamines et derives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20090239865A1 (fr) |
| EP (1) | EP1817297A1 (fr) |
| JP (1) | JP2008520645A (fr) |
| KR (1) | KR20070069213A (fr) |
| AP (1) | AP2007003980A0 (fr) |
| AR (1) | AR053784A1 (fr) |
| AU (1) | AU2005308584A1 (fr) |
| BR (1) | BRPI0518476A2 (fr) |
| CA (1) | CA2589322A1 (fr) |
| CR (1) | CR9089A (fr) |
| EA (1) | EA200700924A1 (fr) |
| GT (1) | GT200500339A (fr) |
| IL (1) | IL183133A0 (fr) |
| MA (1) | MA29039B1 (fr) |
| MX (1) | MX2007006137A (fr) |
| NL (1) | NL1030486C2 (fr) |
| NO (1) | NO20073025L (fr) |
| PE (1) | PE20061124A1 (fr) |
| TN (1) | TNSN07200A1 (fr) |
| TW (1) | TW200630350A (fr) |
| UY (1) | UY29222A1 (fr) |
| WO (1) | WO2006056854A1 (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| DK1848430T3 (da) | 2004-12-31 | 2017-11-06 | Dr Reddys Laboratories Ltd | Nye benzylamin-derivativer som cetp-inhibitors |
| US20100167986A1 (en) * | 2005-09-30 | 2010-07-01 | Amjad Ali | Cholesteryl Ester Transfer Protein Inhibitors |
| EP1981342B1 (fr) * | 2005-12-28 | 2016-11-30 | Dr. Reddy's Laboratories Ltd. | Derives de benzylamine selectifs et leur utilite en tant qu'inhibiteurs de la proteine de transfert de l'ester de cholesterol |
| BRPI0620754A2 (pt) * | 2005-12-29 | 2011-11-22 | Novartis Ag | derivados de amina de piridinila como inibidores de proteìna de transferência de éster de colesterila (cetp) |
| PE20071025A1 (es) * | 2006-01-31 | 2007-10-17 | Mitsubishi Tanabe Pharma Corp | Compuesto amina trisustituido |
| UY30117A1 (es) | 2006-01-31 | 2007-06-29 | Tanabe Seiyaku Co | Compuesto amina trisustituido |
| US8383660B2 (en) * | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| WO2007128568A1 (fr) | 2006-05-10 | 2007-11-15 | Novartis Ag | Dérivés bicycliques utilisés comme inhibiteurs de cetp |
| EP2018376A1 (fr) * | 2006-05-11 | 2009-01-28 | Novartis Pharma AG | Dérivés de la benzylamine en tant qu'inhibiteurs de la cetp |
| US7750019B2 (en) | 2006-08-11 | 2010-07-06 | Kowa Company, Ltd. | Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same |
| US7790737B2 (en) | 2007-03-13 | 2010-09-07 | Kowa Company, Ltd. | Substituted pyrimidine compounds and their utility as CETP inhibitors |
| NZ580777A (en) * | 2007-04-13 | 2011-05-27 | Kowa Co | Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| JP4834699B2 (ja) * | 2007-07-30 | 2011-12-14 | 田辺三菱製薬株式会社 | 医薬組成物 |
| JP4846769B2 (ja) * | 2007-07-30 | 2011-12-28 | 田辺三菱製薬株式会社 | 医薬組成物 |
| AU2008326309C1 (en) * | 2007-11-21 | 2015-03-12 | Decode Genetics Ehf | Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders |
| EP2222638A2 (fr) * | 2007-11-21 | 2010-09-01 | Decode Genetics EHF | Inhibiteurs de pde4 biaryle pour traiter une inflammation |
| NZ587709A (en) | 2008-02-01 | 2012-06-29 | Panmira Pharmaceuticals Llc | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| UA98839C2 (en) * | 2008-02-01 | 2012-06-25 | Панмира Фармасьютикалз, Ллк. | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| JP2011512359A (ja) | 2008-02-14 | 2011-04-21 | アミラ ファーマシューティカルズ，インク． | プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物 |
| JP2011513242A (ja) | 2008-02-25 | 2011-04-28 | アミラ ファーマシューティカルズ，インク． | プロスタグランジンｄ２受容体アンタゴニスト |
| WO2009145989A2 (fr) | 2008-04-02 | 2009-12-03 | Amira Pharmaceuticals, Inc. | Antagonistes d’aminoalkylphényle de récepteurs de prostaglandine d<sb>2</sb> |
| GB2463788B (en) | 2008-09-29 | 2010-12-15 | Amira Pharmaceuticals Inc | Heteroaryl antagonists of prostaglandin D2 receptors |
| US8378107B2 (en) | 2008-10-01 | 2013-02-19 | Panmira Pharmaceuticals, Llc | Heteroaryl antagonists of prostaglandin D2 receptors |
| WO2010042652A2 (fr) | 2008-10-08 | 2010-04-15 | Amira Pharmaceuticals, Inc. | Antagonistes hétéroalkyl biphényle des récepteurs de la prostaglandine d2 |
| US8383654B2 (en) | 2008-11-17 | 2013-02-26 | Panmira Pharmaceuticals, Llc | Heterocyclic antagonists of prostaglandin D2 receptors |
| WO2010059838A2 (fr) * | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Inhibiteurs de pde4 sélectifs pour la forme longue de pde4 pour traiter une inflammation et éviter des effets secondaires |
| EP2462110A4 (fr) | 2009-08-05 | 2013-04-03 | Panmira Pharmaceuticals Llc | Antagoniste de dp2 et ses utilisations |
| PH12012501349A1 (en) | 2010-01-06 | 2013-01-14 | Panmira Pharmaceuticals Llc | Dp2 antagonist and uses thereof |
| EP2612669A4 (fr) | 2010-08-31 | 2014-05-14 | Snu R&Db Foundation | Utilisation de la reprogrammation f tale d'un agoniste des ppar |
| CA2841117A1 (fr) * | 2011-07-08 | 2013-01-17 | Novartis Ag | Derives de 1,2-disubstitue-4-benaylamino-piperidinyl comme inhibiteurs de cetp utiles pour le traitement de l'atherosclerose chez les sujets ayant un niveau eleve de triglycerides |
| EP2744803A2 (fr) * | 2011-08-18 | 2014-06-25 | Dr. Reddy's Laboratories Ltd. | Composés amines hétérocycliques substitués comme inhibiteurs de la protéine de transfert d'ester cholesterylique (cetp) |
| CN103958511A (zh) | 2011-09-27 | 2014-07-30 | 雷迪博士实验室有限公司 | 作为胆固醇酯转移蛋白(CETP)抑制剂用于治疗动脉粥样硬化的5-苄基氨基甲基-6-氨基吡唑并[3,4-b]吡啶衍生物 |
| US9717714B2 (en) | 2012-12-19 | 2017-08-01 | Merck Sharp & Dohme Corp. | Spirocyclic CETP inhibitors |
| PT3762368T (pt) | 2018-03-08 | 2022-05-06 | Incyte Corp | Compostos de aminopirazina diol como inibidores de pi3k-y |
| WO2020010003A1 (fr) | 2018-07-02 | 2020-01-09 | Incyte Corporation | DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ |
| CN115677572B (zh) * | 2021-07-29 | 2024-05-28 | 武汉思瓴生物科技有限公司 | 氟代酰胺类衍生物、药物组合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004529097A (ja) * | 2001-02-15 | 2004-09-24 | ファイザー・プロダクツ・インク | Ｐｐａｒアゴニスト |
| JP2003221376A (ja) * | 2001-11-21 | 2003-08-05 | Japan Tobacco Inc | Ｃｅｔｐ活性阻害剤 |
| US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
| CA2562082C (fr) * | 2004-04-13 | 2013-06-25 | Merck & Co., Inc. | Inhibiteurs de la cetp pour le traitement et la prevention de l'atherosclerose |
-
2005
- 2005-11-21 WO PCT/IB2005/003500 patent/WO2006056854A1/fr active Application Filing
- 2005-11-21 US US11/719,885 patent/US20090239865A1/en not_active Abandoned
- 2005-11-21 PE PE2005001363A patent/PE20061124A1/es not_active Application Discontinuation
- 2005-11-21 KR KR1020077011611A patent/KR20070069213A/ko not_active Application Discontinuation
- 2005-11-21 CA CA002589322A patent/CA2589322A1/fr not_active Abandoned
- 2005-11-21 TW TW094140833A patent/TW200630350A/zh unknown
- 2005-11-21 JP JP2007542159A patent/JP2008520645A/ja not_active Withdrawn
- 2005-11-21 EP EP05805656A patent/EP1817297A1/fr not_active Withdrawn
- 2005-11-21 AR ARP050104864A patent/AR053784A1/es unknown
- 2005-11-21 AP AP2007003980A patent/AP2007003980A0/xx unknown
- 2005-11-21 MX MX2007006137A patent/MX2007006137A/es unknown
- 2005-11-21 BR BRPI0518476-2A patent/BRPI0518476A2/pt not_active Application Discontinuation
- 2005-11-21 AU AU2005308584A patent/AU2005308584A1/en not_active Abandoned
- 2005-11-21 EA EA200700924A patent/EA200700924A1/ru unknown
- 2005-11-22 UY UY29222A patent/UY29222A1/es not_active Application Discontinuation
- 2005-11-22 NL NL1030486A patent/NL1030486C2/nl not_active IP Right Cessation
- 2005-11-23 GT GT200500339A patent/GT200500339A/es unknown
-
2007
- 2007-04-30 CR CR9089A patent/CR9089A/es not_active Application Discontinuation
- 2007-05-10 IL IL183133A patent/IL183133A0/en unknown
- 2007-05-22 TN TNP2007000200A patent/TNSN07200A1/fr unknown
- 2007-05-23 MA MA29936A patent/MA29039B1/fr unknown
- 2007-06-13 NO NO20073025A patent/NO20073025L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0518476A2 (pt) | 2008-11-18 |
| CA2589322A1 (fr) | 2006-06-01 |
| TW200630350A (en) | 2006-09-01 |
| MX2007006137A (es) | 2007-07-19 |
| PE20061124A1 (es) | 2006-10-13 |
| KR20070069213A (ko) | 2007-07-02 |
| TNSN07200A1 (fr) | 2008-11-21 |
| JP2008520645A (ja) | 2008-06-19 |
| AP2007003980A0 (en) | 2007-06-30 |
| NO20073025L (no) | 2007-08-20 |
| EP1817297A1 (fr) | 2007-08-15 |
| WO2006056854A1 (fr) | 2006-06-01 |
| US20090239865A1 (en) | 2009-09-24 |
| EA200700924A1 (ru) | 2007-10-26 |
| GT200500339A (es) | 2006-06-22 |
| NL1030486C2 (nl) | 2006-10-24 |
| NL1030486A1 (nl) | 2006-05-24 |
| AU2005308584A1 (en) | 2006-06-01 |
| AR053784A1 (es) | 2007-05-23 |
| IL183133A0 (en) | 2007-09-20 |
| UY29222A1 (es) | 2006-06-30 |
| CR9089A (es) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA29039B1 (fr) | Dibenzylamines et derives | |
| LUC00127I1 (fr) | Dacomitinib et ses derives pharmaceutiquement accepatbles ( vizimpro ) | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE340782T1 (de) | Piperidinbenzolsulfonamidderivate | |
| ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
| ATE540935T1 (de) | Chinazolinderivate | |
| ATE352550T1 (de) | Chinazolinderivate | |
| ATE420066T1 (de) | Amidoacetonitrilderivate | |
| ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
| EP1731506A4 (fr) | Derives de 5-hydroxyindol-3-carboxylate et leur utilisation | |
| ATE413389T1 (de) | Chinazolinderivate | |
| ATE395345T1 (de) | Imidazol-4-yl-ethynyl-pyridin-derivate | |
| IS8364A (is) | N-þíasól-2-ýl-bensamíð afleiður | |
| DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
| DE112005000241A5 (de) | Möbel | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
| ATE500227T1 (de) | Amidderivate | |
| DE602005020158D1 (de) | Glucanderivate und herstellungsverfahren dafür | |
| ATE449064T1 (de) | Amidoacetonitrilderivate | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| EP1737458A4 (fr) | Derives de r(-)-11-hydroxyaporphines et utilisations de ces derives | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| IS8045A (is) | Púrín-6-ón-afleiður |